Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Pfizer
Pfizer
NiKang Therapeutics, Inc.
DL Analytics
Yuri Semenyuk Rivne Regional Clinical Hospital
Endeavor Health
NiKang Therapeutics, Inc.
University of Minnesota
Karyopharm Therapeutics Inc
Karolinska Institutet
Mabwell (Shanghai) Bioscience Co., Ltd.
Elucida Oncology
Federico II University
Advaxis, Inc.
Kaiser Permanente
Imperial College London
Genexine, Inc.
Novartis
Campus Bio-Medico University
GlaxoSmithKline